市场调查报告书
商品编码
1468358
泌尿科机器人手术市场报告按组件(机器人手术系统、仪器和配件、服务)、应用(机器人前列腺切除术、机器人膀胱切除术、机器人肾盂成形术、机器人肾切除术等)和地区2024-2032Urology Robotic Surgery Market Report by Component (Robotic Surgery Systems, Instruments and Accessories, Services), Application (Robotic Prostatectomy, Robotic Cystectomy, Robotic Pyeloplasty, Robotic Nephrectomy, and Others), and Region 2024-2032 |
IMARC Group年,全球泌尿机器人手术市场规模达18亿美元。骨退化性疾病和肾臟或泌尿道疾病的盛行率不断增加,特别是在老年人群中,以及对膝关节和髋关节置换术的微创辅助手术的需求不断增长,是推动市场的一些关键因素。
泌尿科机器人手术是一种微创治疗,包括微型电脑控制的机械手和带有摄影机和人工感测解决方案的手术器械。这些设备在医疗保健专业人员的监督下,透过各种机器人控制台放置在小穿孔中,而不是大切口中,以到达远处和关键的空间,并查看待手术区域的高度放大且清晰的三维( 3D) 图片。它包括机器人、导航系统、模拟器、规划器和其他关键配件作为标准设备类型。泌尿外科机器人手术可提供精确的运动和更高的放大倍率,最大限度地提高生产力,确保治疗过程中的同侪协作,并最大限度地减少恢復时间、失血量和术后併发症。除此之外,它还可以减少疤痕、疼痛、不适和感染风险,确保缩短住院时间并提供更好的临床结果。因此,泌尿科机器人手术在医院和诊所广泛用于前列腺切除术、膀胱切除术、肾切除术和肾盂成形术手术。
肾臟或泌尿道疾病盛行率的增加是推动市场成长的关键因素之一。容易患此类疾病的老年人口的增加也促进了市场的成长。与此一致的是,由于膝关节和髋关节置换术的微创辅助手术相对于传统手术具有多种优势,因此对膝关节和髋关节置换术的微创辅助手术的需求不断增长,这是另一个促进成长的因素。此外,对可显着减少人为错误机会的自动化手术工具的需求不断增长,正在推动市场成长。此外,机器人辅助柔性内视镜与系统的整合使医疗保健从业者能够存取和治疗复杂的解剖结构并提高诊断过程的精度,这有利于市场成长。此外,软体执行的远端运动中心(RCM)和具有复杂运动控制功能的模组化机器人手术系统的出现正在推动市场成长。除此之外,正在进行的研发(R&D)活动旨在製造具有更高功效的泌尿外科手术机器人,并促进手术干预产品的多样化,正在为市场创造积极的前景。其他因素,例如增加医疗保健预算和改善医疗保健基础设施,正在推动市场成长。
The global urology robotic surgery market size reached US$ 1.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.1 Billion by 2032, exhibiting a growth rate (CAGR) of 9.2% during 2024-2032. The increasing prevalence of bone degenerative and kidney or urinary tract diseases, especially amongst the geriatric population, along with the rising demand for minimally invasive assisted surgeries for knee and hip replacements, represent some of the key factors driving the market.
Urology robotic surgery is a minimally invasive treatment that includes miniaturized computer-controlled manipulators and surgical instruments with a video camera and artificial sensing solutions. These devices are placed in small punctures instead of large incisions by various robotic consoles under the supervision of healthcare professionals to reach distant and critical spaces and view highly magnified and clear three-dimensional (3D) pictures of the area to be operated. It encompasses robotic machines, navigation systems, simulators, planners, and other crucial accessories as standard equipment types. Urology robotic surgery offers accurate motions and increased magnification, maximizes productivity, ensures peer collaborations during treatment procedures, and minimizes recovery time, blood loss, and post-surgical complications. Apart from this, it reduces scarring, pain, discomfort, and the risk of infection ensures shorter hospitalization and provides better clinical outcomes. As a result, urology robotic surgeries are extensively utilized in hospitals and clinics for prostatectomy, cystectomy, nephrectomy, and pyeloplasty surgical procedures.
The increasing prevalence of kidney or urinary tract diseases represents one of the key factors driving the market growth. The increasing geriatric population, which is susceptible to such ailments, is also contributing to the market growth. In line with this, the rising demand for minimally invasive assisted surgeries for knee and hip replacements, due to their multiple benefits over traditional surgical procedures, is acting as another growth-inducing factor. Additionally, the rising need for automated surgical tools that significantly reduce the chances of human errors is driving the market toward growth. Moreover, the integration of robot-assisted flexible endoscopes with the system that enables healthcare practitioners to access and treat complex anatomies and enhance precision in diagnostic proceedings is favoring the market growth. Furthermore, the advent of the software-enforced remote center of motion (RCM) and modular robotic surgical systems with complex motion control capability is impelling the market growth. Apart from this, the ongoing research and development (R&D) activities to manufacture urology surgical robots with enhanced efficacy and the fueling number of product diversification for surgical interventions are creating a positive outlook for the market. Other factors, such as increasing healthcare budgets and improving healthcare infrastructure, are driving the market growth.
IMARC Group provides an analysis of the key trends in each segment of the global urology robotic surgery market, along with forecasts at the global, regional, and country level from 2024-2032. Our report has categorized the market based on component and application.
Robotic Surgery Systems
Instruments and Accessories
Services
The report has also provided a detailed breakup and analysis of urology robotic surgery market based on the component. This includes robotic surgery systems, instruments and accessories and services. According to the report, instruments and accessories represented the largest segment.
Robotic Prostatectomy
Robotic Cystectomy
Robotic Pyeloplasty
Robotic Nephrectomy
Others
A detailed breakup and analysis of the urology robotic surgery market based on the application has also been provided in the report. This includes robotic prostatectomy, robotic cystectomy, robotic pyeloplasty, robotic nephrectomy and others. According to the report, robotic prostatectomy accounted for the largest market share.
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for urology robotic surgery. Some of the factors driving the North America urology robotic surgery market included the increasing prevalence of kidney and urinary tract diseases and the rising geriatric population.
The report has also provided a comprehensive analysis of the competitive landscape in the global urology robotic surgery market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Intuitive Surgical Inc., Johnson & Johnson, Medtronic plc, Stryker Corporation, Surgical Science Sweden AB, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.